Moleculin Biotech, Inc. (MBRX)
4.70
+0.44
(+10.33%)
USD |
NASDAQ |
Jan 21, 15:50
Moleculin Biotech Market Cap: 9.729M for Jan. 21, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 4.521B |
| Harvard Bioscience, Inc. | 26.33M |
| Intensity Therapeutics, Inc. | 23.83M |
| NovaBay Pharmaceuticals, Inc. | 739.38M |
| Palatin Technologies, Inc. | 15.40M |
Market Cap Related Metrics
| Price | 4.70 |
| Earnings Yield | -934.8% |